Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q1 · 10,6 OA 34 matched articles SCIE

Journal detail

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Publisher
SAGE Publications Ltd
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 14703203
  • 17528976
Scopus 1,02 SJR
Scopus Q2 SJR Q
WoS Q1 JCR Q
WoS 10,6 JIF
Scopus 54 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 1,02
  • Quartile Q2
  • H-Index 54
  • Cites/doc 6,86
  • Docs (3y) 40
  • Cites (3y) 230

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q1
  • JIF 10,6
  • 5Y JIF 4,3
  • JCI 1,09

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Endocrinology Q2
  • Internal Medicine Q2

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

WoS categories

  • Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q1 1,02 10,6 4,3 1,09 Q1 54
2024 Q2 Q1 0,75 4,1 2,5 0,66 Q2 52
2023 Q2 Q3 0,556 2,1 1,9 0,51 Q3 52
2022 Q2 Q2 0,574 2,9 2,2 0,48 Q3 52
2021 Q3 Q2 0,554 4,1 2,8 0,47 Q3 52
2020 Q3 Q4 0,457 1,6 2 0,33 Q4 52
2019 Q3 Q4 0,463 1,4 1,3 0,3 Q4 52
2018 — Q4 — 1,4 1,2 0,29 Q4 —
2017 Q3 Q4 0,52 1,2 1,2 0,31 Q4 52
2016 Q3 Q4 0,495 1,4 1,5 — — 52
2015 Q2 Q3 0,592 2,4 2,3 — — 52
2014 Q2 Q3 0,678 2,4 2,2 — — 52
2013 Q2 Q3 0,747 2,3 2 — — 52
2012 Q1 Q3 0,763 2,3 2,1 — — 52
2011 Q2 Q2 0,628 2,4 2 — — 52
2010 Q2 Q3 0,662 1,6 1,8 — — 52
2009 — Q3 — 2 1,7 — — —
2008 — Q3 — 1,9 1,7 — — —
2007 — Q4 — 0,9 1,1 — — —
2006 — Q4 — 1 — — — —
2005 — Q3 — 1,2 — — — —
2004 — Q3 — 1,1 — — — —
2003 — Q4 — 0,9 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PERIPHERAL VASCULAR DISEASE SCIE Q1 Q1 6/100
2024 PERIPHERAL VASCULAR DISEASE SCIE Q1 Q2 21/98
2023 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 51/96
2022 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q3 34/68
2021 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q3 29/67
2020 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 59/65
2019 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 55/65
2018 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 57/65
2017 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 58/65
2016 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 51/63
2015 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 37/63
2014 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 36/60
2013 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 36/65
2012 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 36/68
2011 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 32/68
2010 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 41/68
2009 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 32/61
2008 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 33/56
2007 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 47/54
2006 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 43/52
2005 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 38/51
2004 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 34/51
2003 PERIPHERAL VASCULAR DISEASE SCIE Q4 — 41/52